AMENDMENT AND CLARIFICATION TO 1/11/2018 RELEASE : ENTRY INTO CANNABIS TECH SECTOR CALIPHARMS 2018 GROWTH STRATEGY
13 Febrero 2018 - 5:22AM
InvestorsHub NewsWire
Riverside, CA -- February 13, 2018 -- InvestorsHub NewsWire
-- CaliPharms, Inc. (OTCPink:
KGET), a Development Stage Company operating in the California
Medicinal Cannabis Industry, publicly trading under the OTC Markets
symbol "KGET" releases its growth plans for 2018.
CaliPharms has expanded its acquisition model into the Cannabis
Tech Sector with a medical cannabis delivery app. The Company has
already met three times with a cannabis delivery blockchain app
developer that could expand the CaliPharms business model into the
cannabis tech sector.
According to the app developer in laymen's terms; the App was
developed to deliver Cannabis and Cannabis related products to
legal use home users with a similar type of customer coordination
as the Uber App. The App would not physically touch the product,
but it would connect customers to drivers and bill the customers
using the block-chain internal software. Essentially the system
could allow customers to pay by credit card and have the products
delivered to their home. An internal cryptocurrency would be used
to complete each transaction. The company would have to hold actual
Government Currency within its account to bridge each transaction
from delivery to doorstep.
CaliPharms President Bo Linton stated, “We continue our meetings
with potential acquisition candidates within the Cannabis Industry.
So far this year we have already had very promising meetings with
companies to discuss acquisition roll ups in the following;
Cannabis Delivery Blockchain App, Extraction Oils, Vape Pens, Vape
Cartridges, and Cannabis farms within the State of
California.”
Linton continued, “I was hesitant to put out a press
releases using the word “Block-chain” as the SEC has stated the
following in a recent Bloomberg article. https://www.bloomberg.com/news/articles/2018-01-31/signaling-crackdown-sec-boss-emerges-as-crypto-skeptic-in-chief.
However; it would be unfair to not disclose to our shareholders the
progress and business models we are actively pursuing. The
blockchain application we are working to acquire has been described
to the Company as a medical cannabis delivery application which
uses the blockchain for billing purposes. Until we sign an official
agreement and hire an expert in blockchain code as a Chief
Technical Officer, I recommend investors use extreme caution when
considering an investment into CaliPharms if that decision is based
solely on the block-chain or cryptocurrency investment frenzy
currently taking place. CaliPharms has no intentions to raise money
in an Initial Coin Offering, (ICO) at this time. CaliPharms would
ONLY explore the ICO at such time the SEC has determined it as a
valid and SEC regulated investment.”
Please see our company videos
Company Vision
https://youtu.be/UNjImyPw1Oc
Business Vision
https://youtu.be/TCTrG_EC4VU
For up to date information on the company please follow us @
facebook.com/CaliPharms
twitter.com/CaliPharms
About CaliPharms, Inc.
CaliPharms Inc., trading under the symbol (KGET)
which trades under its former name Kleangas Energy Technologies,
Inc. is a development stage medical marijuana-cannabis business.
The Company currently is focused within the medical
marijuana-cannabis industry. The company intends to expand into
other sectors that support the legalized cannabis industry as the
laws for each individual State and the Federal Government change
and allow.
Safe harbor from liability established by the Private Securities
Litigation Reform Act of 1995. These forward-looking statements
generally can be identified by phrases such as CaliPharms or KGET
or its management "believes," "expects," "anticipates," "foresees,"
"forecasts," "estimates" or other words or phrases of similar
import. Similarly, statements herein that describe the Company's
business strategy, outlook, objectives, plans, intentions or goals
also are forward-looking statements. All such forward-looking
statements are subject to certain risks and uncertainties that
could cause actual results to differ materially from those in
forward-looking statements. Investment into a microcap company is a
high risk investment and it should only be considered if you are
able to afford a total loss of the investment. Laws and Regulations
of Marijuana are currently in direct contradiction between
California and Federal Law and these factors should be a part of
your consideration when making an investment into KGET.
Company Contact:
CaliPharms, Inc. (KGET)
www.CaliPharmsInc.com
facebook.com/CaliPharms
twitter.com/CaliPharms
Telephone 1-949-800-6645
Email: info@CaliPharmsInc.com
Kleangas Energy Technolo... (CE) (USOTC:KGET)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Kleangas Energy Technolo... (CE) (USOTC:KGET)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024